NEW YORK (GenomeWeb) – Embark Veterinary announced today that it has raised $4.5 million in order to expand its suite of canine genetic tests. The consumer genomics company said it has also relocated its headquarters.

According to Embark, its latest round of financing was led by Cambridge, Massachusetts-based Founder Collective, San Francisco-based Freestyle Capital, and Third Kind, a New York venture capital fund.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.